Regresa al Registro Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorJanjigian, Yelena
dc.contributor.authorVan Cutsem, Eric
dc.contributor.authorMuro, Kei
dc.contributor.authorWainberg, Zev
dc.contributor.authorAl-Batran, Salah-Eddin
dc.contributor.authorHyung, Woo Jin
dc.contributor.authorTabernero Caturla, Josep
dc.date.accessioned2022-09-06T11:20:26Z
dc.date.available2022-09-06T11:20:26Z
dc.date.issued2022-06
dc.identifier.citationJanjigian YY, Van Cutsem E, Muro K, Wainberg Z, Al-Batran SE, Hyung WJ, et al. MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer. Futur Oncol. 2022 Jun;18(20):2465–2473.
dc.identifier.issn1479-6694
dc.identifier.urihttp://hdl.handle.net/11351/8033
dc.descriptionQuimioterapia; Durvalumab; Cáncer gástrico
dc.language.isoeng
dc.publisherFuture Medicine
dc.relation.ispartofseriesFuture Oncology;18(20)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectEstómac - Càncer - Tractament
dc.subjectQuimioteràpia combinada
dc.subject.meshStomach Neoplasms
dc.subject.mesh/drug therapy
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols
dc.subject.meshNeoadjuvant Therapy
dc.titleMATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.2217/fon-2022-0093
dc.subject.decsneoplasias gástricas
dc.subject.decs/farmacoterapia
dc.subject.decsprotocolos de quimioterapia antineoplásica combinada
dc.subject.decstratamiento neoadyuvante
dc.relation.publishversionhttps://doi.org/10.2217/fon-2022-0093
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Janjigian YY] Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. [Van Cutsem E] Department of Gastroenterology/Digestive Oncology, University Hospitals Leuven & KU Leuven, Leuven, 3000, Belgium. [Muro K] Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, 464-8681, Japan. [Wainberg Z] Department of Gastrointestinal Medical Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90404, USA. [Al-Batran SE] Institute of Clinical Cancer Research, Krankenhaus Nordwest, University Cancer Center, Frankfurt, 60488, Germany. [Hyung WJ] Department of Surgery, Yonsei University College of Medicine, Seoul, 03722, South Korea. [Tabernero J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron, UVic-UCC, Barcelona, 08035, Spain
dc.identifier.pmid35535555
dc.identifier.wos000804192000001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Regresa al Registro Simple